Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease

NCT05101824 NA ACTIVE_NOT_RECRUITING

This is a prospective, investigator-initiated, phase II, multicentre-study, investigating the efficacy and toxicity of definitive SABR of osseous oligometastases, when pragmatically introduced into a daily clinical setting.

Details

Lead sponsor	Gitte Fredberg Persson MD PhD
Phase	NA
Status	ACTIVE_NOT_RECRUITING
Enrolment	67
Start date	Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Oligometastatic Disease
• Bone Metastases
• Stereotactic Body Radiotherapy

Interventions

• SABR

Countries

Denmark, Norway